Висмодегиб

Introduction: What is Vismodegib?

Vismodegib is a medication primarily used in the treatment of certain types of skin cancer, specifically basal cell carcinoma (BCC). It belongs to a class of drugs known as hedgehog pathway inhibitors. By targeting specific molecular pathways involved in cancer growth, Vismodegib helps to slow down or stop the progression of tumors. It was first approved by the FDA in 2012 and has since become an important option for patients with advanced or metastatic BCC.

Uses of Vismodegib

Vismodegib is primarily approved for the treatment of:

• Metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery, and who are not candidates for radiation.
• Symptomatic cutaneous basal cell carcinoma in adults with nevoid basal cell carcinoma syndrome (Gorlin syndrome).

Како то функционише?

Vismodegib works by inhibiting the hedgehog signaling pathway, which is crucial for cell growth and development. In many cancers, including BCC, this pathway is abnormally activated, leading to uncontrolled cell proliferation. By blocking this pathway, Vismodegib effectively reduces the growth of cancer cells, helping to shrink tumors and prevent new ones from forming.

Дозирање и администрација

Vismodegib is administered orally in the form of a tablet. The standard dosage for adults is typically 150 mg taken once daily. It is important to take the medication consistently at the same time each day, with or without food.

Side Effects of Vismodegib

Like all medications, Vismodegib can cause side effects. Common side effects include:

• Грчење мишића
• Губитак косе
• Губитак тежине
• Умор
• Мучнина
• Дијареја
• Altered taste (dysgeusia)
• смањен апетит

Озбиљни нежељени ефекти могу укључивати:

• Урођене мане ако се узимају током трудноће
• Тешке кожне реакције
• Проблеми са јетром
• Myelosuppression or cytopenias

Пацијенти треба одмах да пријаве све необичне симптоме свом лекару.

Друг интеракције

Vismodegib may interact with several medications, which can affect how it works or increase the risk of side effects. Major drug interactions include:

• Инхибитори ЦИП3А4: Medications that inhibit this enzyme can increase Vismodegib levels in the body, leading to increased side effects.
• Индуктори ЦИП3А4: These can decrease the effectiveness of Vismodegib by lowering its levels.

Увек обавестите свог лекара о свим лековима и суплементима које узимате.

Предности Висмодегиба

The clinical advantages of Vismodegib include:

• Циљана терапија: It specifically targets the hedgehog pathway, which is often overactive in BCC, leading to more effective treatment with potentially fewer side effects compared to traditional chemotherapy.
• Неинвазивно: As an oral medication, it offers a noninvasive treatment option for patients who may not be suitable for surgery.
• Побољшани резултати: Studies (ERIVANCE/STEVIE) show objective response rates (tumor shrinkage) of ~40-60% in patients with advanced BCC.

Contraindications of Vismodegib

Certain individuals should avoid using Vismodegib, including:

• Труднице: Vismodegib can cause severe birth defects and should not be used during pregnancy.
• Алергијске реакције: Individuals with known hypersensitivity to Vismodegib or any of its components should not take this medication.

Мере предострожности и упозорења

Before starting Vismodegib, patients should undergo certain evaluations, including:

• Тест на трудноћу: Verify pregnancy status of females of reproductive potential within 7 days prior to initiating therapy; use effective contraception during treatment and for 24 months after in females (3 months in males).
• Тестови функције јетре: Препоручује се редовно праћење функције јетре, посебно код пацијената са постојећим обољењима јетре.
• Кожне реакције: Patients should be monitored for any severe skin reactions, and any new or worsening symptoms should be reported immediately.

ФАК

• What is Vismodegib used for? Vismodegib is used to treat metastatic or locally advanced basal cell carcinoma (recurrent after surgery, not candidates for surgery/radiation) and symptomatic cutaneous BCC in nevoid basal cell carcinoma syndrome in adults.
• How is Vismodegib taken? Узима се орално као таблета, обично 150 мг једном дневно.
• Који су уобичајени нежељени ефекти? Common side effects include muscle spasms, hair loss, weight loss, fatigue, nausea, diarrhea, altered taste (dysgeusia), and decreased appetite.
• Can Vismodegib be taken during pregnancy? No, Vismodegib can cause severe birth defects and should not be taken during pregnancy.
• Да ли постоје интеракције са лековима? Yes, Vismodegib can interact with certain medications, especially those affecting liver enzymes.
• How does Vismodegib work? It inhibits the hedgehog signaling pathway, which is often overactive in basal cell carcinoma.
• Шта да радим ако пропустим дозу? Узмите пропуштену дозу чим се сетите, али је прескочите ако је скоро време за следећу дозу. Немојте удвостручити дозу.
• Can children take Vismodegib? It is not approved for pediatric use; safety and efficacy is not established.
• Које мере предострожности треба да предузмем? Regular liver function tests and pregnancy testing for women of childbearing age are recommended.
• How long will I need to take Vismodegib? Трајање лечења варира у зависности од индивидуалног одговора и о томе треба разговарати са својим лекаром.

Бранд Намес

Vismodegib is marketed under the brand name Erivedge.

Закључак

Vismodegib represents a significant advancement in the treatment of advanced basal cell carcinoma, offering a targeted approach that can improve patient outcomes. While it is effective, it is essential for patients to be aware of potential side effects, drug interactions, and contraindications. Always consult with a healthcare provider for personalized advice and treatment plans.